Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Partners With GeneCast to Launch Tests in China

NEW YORK (GenomeWeb) — Agendia today announced a partnership with GeneCast Biotechnology to make its breast cancer tests available in China.

Under the terms of the deal, Beijing-based GeneCast has the exclusive right to market Agendia's MammaPrint and BluePrint tests to Chinese customers. Local physicians will be able to send patient samples to GeneCast's oncology laboratory for testing, the firms said.

Franklin Libenson, senior VP of strategic marketing and marketing development for Amsterdam-based Agendia, said that China is a "significant market with an urgent need" for MammaPrint and BluePrint.

MammaPrint analyzes 70 genes associated with breast cancer recurrence to provide a low or high risk of cancer recurrence, enabling physicians to decide which individuals can forgo chemotherapy. Agendia's BluePrint test interrogates 80 genes and classifies a patient's breast cancer into one of four functional molecular subtypes.

Agendia, which maintains a US office in Irvine, California, has been moving to a decentralized testing model in recent months, and inked a marketing agreement with Singapore-based Angsana Molecular & Diagnostics Laboratory covering multiple Southeast Asian countries in May.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.